Abu Dhabi Stem Cells Center (ADSCC) announced promising results of a revolutionary advancement in the management of diabetes, successfully performing umbilical cord-derived mesenchymal stem cell ...

"Congratulations!" "Er, thanks — what for?" "For beating cancer!" Congratulations are certainly due but not to me. I was just ...

Abu Dhabi Stem Cells Centre (ADSCC) announced promising results of a revolutionary advancement in the management of diabetes, successfully performing umbilical cord-derived mesenchymal stem cell ...

Colossal Biosciences, which aims to revive extinct species, has raised an additional $200 million. Critics say de-extinction ...

Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.

Oncology nurses can educate patients on the benefits of subcutaneous administration, including reduced time in the infusion ...

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

Be Biopharma has secured $92m in a Series C financing round to advance its clinical programmes for haemophilia B and ...

Molecular Partners' DARPin platform shows promise, but future funding is uncertain. Learn why MOLN stock could be a risky, ...

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

Eculizumab, a monoclonal antibody, is indicated for the treatment of two rare and life-threatening conditions: Paroxysmal ...